Abstract:Rapid and accurate diagnostic approaches are essential for impeding the spread of infectious diseases. This review aims to summarize current progress of clustered regularly interspaced short palindromic repeats (CRISPR)‐associated (Cas) systems in the applications for diagnostics of infectious diseases including the ongoing COVID-19 epidemic.In this review, we discuss class 2 CRISPR-Cas biosensing systems-based diagnostics in various emerging and reemerging infectious diseases, CRISPR-Cas systems have created a new era for early diagnostics of infectious diseases, especially with the discovery of the collateral cleavage activity of Cas12 and Cas13. We mainly focus on different CRISPR-Cas effectors for the detection of pathogenic microorganisms as well as provide a detailed explanation of the pros and cons of CRISPR-Cas biosensing systems. In addition, we also introduce future research perspectives.However, further improvement of newly discovered systems and engineering existing ones should be developed to increase the specificity, sensitivity or stability of the diagnostic tools. It may be a long journey to finish the clinical transition from research use. CRISPR-Cas approaches will emerge as more promising and robust tools for infectious disease diagnosis in the future.
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is: **How to use the CRISPR - Cas system to develop rapid, accurate and efficient diagnostic methods for infectious diseases**. Specifically, the article summarizes the latest progress of the CRISPR - Cas system in the diagnosis of infectious diseases, especially in view of the current COVID - 19 epidemic.
### Core issues of the paper
1. **Requirement for rapid and accurate diagnosis**:
- Infectious diseases (such as those caused by bacteria, viruses, fungi and parasites) pose a major threat to human health.
- Rapid identification of pathogens and early diagnosis are crucial for controlling the spread of infectious diseases.
2. **Limitations of existing diagnostic methods**:
- Existing diagnostic methods such as pathogen culture, protein - based detection and nucleic - acid - based detection have some shortcomings, such as being time - consuming, requiring expensive equipment or having low sensitivity and specificity.
- Traditional techniques such as PCR/QPCR and next - generation sequencing are commonly used, but they require complex equipment and a high level of professional skills, which limits their wide application.
3. **Potential of the CRISPR - Cas system**:
- As a new type of nucleic - acid detection tool, the CRISPR - Cas system has the advantages of being rapid, sensitive and highly specific, and can meet the "ASSURED" criteria (affordable, sensitive, specific, user - friendly, rapid and robust, equipment - free, easy to deliver) proposed by the World Health Organization (WHO).
- In particular, the discovery of Cas12 and Cas13 proteins and the application of their collateral cleavage activities have brought new hope for the early diagnosis of infectious diseases.
### Specific content of the paper
- **Biological mechanism of the CRISPR - Cas system**: It introduces the classification, function and mechanism of action of the CRISPR - Cas system, and focuses on discussing different effector proteins (such as Cas9, Cas12, Cas13 and Cas14) of the Class 2 CRISPR - Cas system.
- **Application of CRISPR - Cas in the diagnosis of infectious diseases**: It describes in detail various diagnostic methods based on the CRISPR - Cas system, including diagnostic methods based on specific cleavage or DNA binding and diagnostic methods based on collateral cleavage activity.
- **Detection of COVID - 19**: It pays special attention to the application of the CRISPR - Cas system in the detection of SARS - CoV - 2, such as DETECTR, SHERLOCK and other techniques.
### Conclusion and outlook
- **Future research directions**: Although the CRISPR - Cas system has shown great potential in the diagnosis of infectious diseases, further improvement is still needed to enhance its specificity, sensitivity and stability, and promote the transformation of these technologies from laboratory research to clinical applications.
By solving the above problems, this paper aims to provide new ideas and technical means for the rapid and accurate diagnosis of infectious diseases, so as to better meet global public health challenges.